TP53 and cancer: Under drug treatments, increased Cer glycosylation and cellular GSLs may modulate GEMs so as to promote expression of particular proteins, including MDR1, FGF2, and even p53 mutants protecting cells, including cancer cells, against anticancer drugs.16, 17, 20